[CMF-ECG 19/Solution. Electrolyte disturbance].
Brunckhorst
Corinna B
CB
Klinik für Kardiologie, Department Innere Medizin Universitätsspital Zürich.
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D004562:Electrocardiography; D004656:Enalapril / Q000009:adverse effects; D006801:Humans; D006947:Hyperkalemia / Q000097:blood / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis; D017693:Sodium Bicarbonate / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D013566:Sympathomimetics; D004656:Enalapril; D017693:Sodium Bicarbonate; D011188:Potassium